On 12 Feb 2025, Dornier MedTech, Ng Teng Fong General Hospital (NTFGH), A*STAR Institute of High Performance Computing (IHPC), MedTech Catapult, and Singapore Biodesign inked a Research Collaboration Agreement to develop an intelligent laser lithotripsy system.

Back row (L to R): Mr Wong Yau Chung, Group Chief Executive Officer, Advanced MedTech; Ms Irene Cheong, Assistant Chief Executive, Innovation & Enterprise, A*STAR
Front row (L to R): Asst Prof Mary Kan, Programme Director, MedTech Catapult; Asst Prof Heng Chin Tiong, Vice-Chair, Medical Board, Care Transformation, Ng Teng Fong General Hospital; Mr Shadki Chikkanaravangala, Director, Research & Development, Dornier MedTech; Dr Su Yi, Executive Director, Institute of High Performance Computing, A*STAR and Asst Prof Lee Phin Peng, Programme Director, Singapore Biodesign

 

Project Clarity harnesses multidisciplinary expertise across advanced modelling and simulation, and mechanical product system development and integration. With A*STAR IHPC's contributions, the team uses advanced modelling and simulation tool to optimise the laser lithotripsy procedure, enhancing both its effectiveness and safety in kidney stone treatment. A prototype has been developed to validate the concept, with MedTech Catapult supporting component sourcing and refinement to prepare it for user testing.

 

MedTech Catapult is a $38 million national initiative to accelerate the development and commercialisation of life science instruments and medical devices. It provides dedicated support to help medtech innovators and product owners bring their products from concept to market and connects them with local contract manufacturers. Read more on A*STAR launches S$38 million MedTech Catapult to drive medical device commercialisation.